Published in J Endocrinol Invest on April 01, 1998
Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab (2001) 6.12
Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. Blood (2001) 3.66
The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol (2007) 3.51
Increased prevalence of thyroid autoimmunity in patients successfully treated for Cushing's disease. Clin Endocrinol (Oxf) (2000) 2.19
Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment. J Clin Endocrinol Metab (1997) 2.14
Two mutations of BRCA2 gene at exon and splicing site in a woman who underwent oncogenetic counseling. Ann Oncol (2009) 2.13
Impairment of GH secretion in adults with primary empty sella. J Endocrinol Invest (2002) 2.09
Methodology-dependent variation in documentation of outcome predictors in out-of-hospital cardiac arrest. Acad Emerg Med (1995) 2.01
Treatment of skeletal impairment in patients with endogenous hypercortisolism: when and how? Osteoporos Int (2013) 2.00
Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab (2000) 1.99
Dynamics of a nosocomial outbreak of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase. J Clin Microbiol (2001) 1.92
Imatinib inhibits the activation and proliferation of normal T lymphocytes in vitro. Leukemia (2004) 1.84
Effectiveness of bystander cardiopulmonary resuscitation and survival following out-of-hospital cardiac arrest. JAMA (1995) 1.83
Cardiac effects of long term thyrotropin-suppressive therapy with levothyroxine. J Clin Endocrinol Metab (1993) 1.80
Control of adrenergic overactivity by beta-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine. J Clin Endocrinol Metab (1994) 1.69
Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study. J Endocrinol Invest (2002) 1.65
Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. J Clin Endocrinol Metab (1999) 1.62
High prevalence of reflux symptoms in duodenal ulcer patients who develop gastro-oesophageal reflux disease after curing Helicobacter pylori infection. Dig Liver Dis (2001) 1.61
Prostatic hyperplasia: an unknown feature of acromegaly. J Clin Endocrinol Metab (1998) 1.58
Percutaneous computed tomography-guided ethanol injection in aldosterone-producing adrenocortical adenoma. Eur J Endocrinol (1995) 1.56
The molecular basis of alloreactivity. Immunol Today (1990) 1.56
Consensus statement: medical management of acromegaly. Eur J Endocrinol (2005) 1.54
Accuracy of a new monoclonal stool antigen test in post-eradication assessment of Helicobacter pylori infection: comparison with the polyclonal stool antigen test and urea breath test. Dig Liver Dis (2005) 1.52
Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients with GH deficiency. J Clin Endocrinol Metab (2001) 1.51
Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin Endocrinol Metab (2000) 1.49
Guidelines for acromegaly management. J Clin Endocrinol Metab (2002) 1.48
Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels. Clin Endocrinol (Oxf) (2009) 1.46
Spinal deformity index in patients with type 2 diabetes. Endocrine (2012) 1.45
Dental caries and enamel defects in very low birth weight adolescents. Caries Res (2010) 1.44
Bone loss determined by quantitative ultrasonometry correlates inversely with disease activity in patients with endogenous glucocorticoid excess due to adrenal mass. Eur J Endocrinol (2001) 1.44
Human lymphocyte-activating properties of a purified polysaccharide from Candida albicans: B and T cell cooperation in the mitogenic response. J Immunol (1980) 1.44
Identification and antimicrobial susceptibility testing of clinical isolates of nonfermenting gram-negative bacteria by the Phoenix Automated Microbiology System. New Microbiol (2002) 1.43
Growth hormone and heart performance. A novel mechanism of cardiac wall stress regulation in humans. Eur Heart J (1997) 1.43
Peptide analogues as a strategy to induce tolerance in T cells with indirect allospecificity. Transplantation (2000) 1.43
Finasteride in the treatment of hirsutism: new therapeutic perspectives. Fertil Steril (1996) 1.43
Speculations on the specificity of suppression. Immunol Today (1989) 1.43
Antigen presentation by keratinocytes induces tolerance in human T cells. Eur J Immunol (1990) 1.43
NOD2/CARD15 in healthy relatives of IBD patients. Eur Rev Med Pharmacol Sci (2006) 1.41
Different dysregulations in adrenal steroid biosynthesis as a prevalent cause of hyperandrogenism in women from southern Italy. Fertil Steril (1997) 1.40
CV 205-502 treatment in therapy-resistant acromegalic patients. Eur J Endocrinol (1995) 1.40
The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas. Clin Endocrinol (Oxf) (2000) 1.40
Peptide receptor therapies in neuroendocrine tumors. J Endocrinol Invest (2009) 1.39
[Effectiveness of and tolerability to oral desmopressin in the treatment of central diabetes insipidus]. Minerva Med (1992) 1.39
Chronic treatment with CV 205-502 restores the gonadal function in hyperprolactinemic males. Eur J Endocrinol (1996) 1.39
Cardiac arrest witnessed by prehospital personnel: intersystem variation in initial rhythm as a basis for a proposed extension of the Utstein recommendations. Ann Emerg Med (1997) 1.39
The orbital veins. Am J Ophthalmol (1967) 1.39
Chemotherapy-based control of schistosomiasis haematobia. I. Metrifonate versus praziquantel in control of intensity and prevalence of infection. Am J Trop Med Hyg (1988) 1.38
Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells. Clin Exp Immunol (2009) 1.37
Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J Clin Endocrinol Metab (1999) 1.36
Endoscopic endonasal transsphenoidal approach: outcome analysis of 100 consecutive procedures. Minim Invasive Neurosurg (2002) 1.35
Epidemiology of gastroenteropancreatic neuroendocrine tumours. Best Pract Res Clin Gastroenterol (2012) 1.32
Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus--a GISC study. Eur J Hum Genet (1999) 1.32
Anergic T cells inhibit the antigen-presenting function of dendritic cells. J Immunol (2000) 1.32
Generation of suppressor cells in the response of human lymphocytes to a polysaccharide from Candida albicans. J Immunol (1981) 1.31
High prevalence of vitamin D deficiency and its association with left ventricular dilation: an echocardiography study in elderly patients with chronic heart failure. Nutr Metab Cardiovasc Dis (2010) 1.29
Controlled trial of botulinum toxin injection versus placebo and pneumatic dilation in achalasia. Gastroenterology (1996) 1.28
Increased prevalence of colonic polyps and altered lymphocyte subset pattern in the colonic lamina propria in acromegaly. Clin Endocrinol (Oxf) (1997) 1.25
Primary empty sella: Why and when to investigate hypothalamic-pituitary function. J Endocrinol Invest (2010) 1.21
Characterization and sequence of PhoC, the principal phosphate-irrepressible acid phosphatase of Morganella morganii. Microbiology (1994) 1.21
Growth hormone and the heart. Clin Endocrinol (Oxf) (2001) 1.18
Familial expression of anti-Saccharomyces cerevisiae Mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study. Am J Gastroenterol (2001) 1.17
Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly. J Clin Endocrinol Metab (1999) 1.17
The heart: an end-organ of GH action. Eur J Endocrinol (2004) 1.16
Differential expression of CTLA-4 among T cell subsets. Clin Exp Immunol (2004) 1.15
Sildenafil does not improve sexual function in men without erectile dysfunction but does reduce the postorgasmic refractory time. Int J Impot Res (2003) 1.15
Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation. Am J Transplant (2013) 1.14
Significant frequencies of T cells with indirect anti-donor specificity in heart graft recipients with chronic rejection. Circulation (2000) 1.14
Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire. Eur J Endocrinol (2008) 1.14
Diagnostic and prognostic implications of the World Health Organization classification of neuroendocrine tumors. J Endocrinol Invest (2008) 1.14
Antigen recognition influences transendothelial migration of CD4+ T cells. J Immunol (1999) 1.10
Minor H antigens: genes and peptides. Transpl Immunol (2002) 1.09
Is a kit for identification of clinical yeasts correctly evaluated when released onto the market? Eur J Clin Microbiol Infect Dis (2000) 1.09
Inhibition of T cell apoptosis by IFN-beta rapidly reverses nuclear translocation of protein kinase C-delta. Eur J Immunol (1999) 1.09
Incidence of gastroenteropancreatic neuroendocrine tumours: a systematic review of the literature. Endocr Relat Cancer (2014) 1.08